A Study of Long-term Treatment With Deferasirox in Patients With Beta-thalassemia and Transfusional Hemosiderosis
Learn more about:
Related Clinical Trial
Non-invasive Quantification of Liver Iron With MRI
Confounder-Corrected Quantitative MRI Biomarker of Hepatic Iron Content
Efficacy Study in Removing Excess Iron From the Heart
Extension Study of Iron Chelation Therapy With Deferasirox in β-thalassemia and Rare Chronic Anemia Patients
Pharmacogenetic Study in Patients Received Iron Chelating Agent
Safety, Tolerability, and Efficacy of Deferasirox in MDS
A Study of Long-term Treatment With Deferasirox in Patients With Beta-thalassemia and Transfusional Hemosiderosis
Extension Study of the Efficacy and Safety of Deferasirox Treatment in Beta-thalassemia Patients With Transfusional Hemosiderosis (Study Amended to 2-year Duration)